SCM
GLSI icon

Sterling Capital Management’s Greenwich LifeSciences GLSI Stock Holding History

Sterling Capital Management’s Portfolio GLSI Stock Details GLSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$563 Sell
24
-16
-40% -$389 ﹤0.01% 3213
2026
Q1 		$961 Hold
40
– – ﹤0.01% 3102
2025
Q4 		$840 Buy
40
+25
+167% +$263 ﹤0.01% 3152
2025
Q3 		$149 Buy
15
+1
+7% +$11 ﹤0.01% 3228
2025
Q2 		$127 Buy
14
+8
+133% +$76 ﹤0.01% 3247
2025
Q1 		$57 Hold
6
– – ﹤0.01% 3173
2024
Q4 		$67 Hold
6
– – ﹤0.01% 3197
2024
Q3 		$86 Buy
+6
New +$89 ﹤0.01% 3204

Other funds holding GLSI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Sterling Capital Management's GLSI Position: Q2 2026 in Review

Sterling Capital Management reduced its Greenwich LifeSciences (GLSI) stake by 40% in Q2 2026, selling an estimated $389 and leaving 24 shares worth $563. The position accounts for ﹤0.01% of the portfolio, ranked #3213.

Sterling Capital Management first reported a position in GLSI in Q3 2024 and has held it in 8 quarters since. The position peaked at $961 in Q1 2026. 58 funds tracked by Wall St. Rank hold GLSI as of Q2 2026.

  • Sterling Capital Management held 24 shares of Greenwich LifeSciences worth $563 as of Q2 2026.
  • Sterling Capital Management sold 16 Greenwich LifeSciences shares in Q2 2026, an estimated $389.
  • Greenwich LifeSciences made up ﹤0.01% of Sterling Capital Management's portfolio in Q2 2026, its #3213 holding.
  • Sterling Capital Management first reported a position in Greenwich LifeSciences in Q3 2024 and has held it in 8 quarters since.
  • Sterling Capital Management's Greenwich LifeSciences position peaked at $961 in Q1 2026.
  • 58 funds tracked by Wall St. Rank held Greenwich LifeSciences as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.